Arbutus Biopharma Corp Shares Outstanding
Arbutus Biopharma Corp (ABUS) had Shares Outstanding of 197.63 million shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-12
- 2026-06-30: Shares outstanding (split-adjusted) 197.63M shares; Shares authorized (split-adjusted) (m).
- 2026-03-31: Shares outstanding (split-adjusted) 196.95M shares; Shares authorized (split-adjusted) (m).
- 2025-12-31: Shares outstanding (split-adjusted) 192.53M shares; Shares authorized (split-adjusted) (m).
- 2025-09-30: Shares outstanding (split-adjusted) 191.95M shares; Shares authorized (split-adjusted) (m).
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 197.63M shares 10-Q · filed 2026-08-12 | (m) |
| 2026-03-31 | 196.95M shares 10-Q · filed 2026-05-13 | (m) |
| 2025-12-31 | 192.53M shares 10-Q · filed 2026-08-12 | (m) |
| 2025-09-30 | 191.95M shares 10-Q · filed 2025-11-13 | (m) |
| 2025-06-30 | 191.64M shares 10-Q · filed 2025-08-06 | (m) |
| 2025-03-31 | 191.48M shares 10-Q · filed 2025-05-14 | (m) |
| 2024-12-31 | 189.96M shares 10-K · filed 2026-03-23 | (m) |
| 2024-09-30 | 189.44M shares 10-Q · filed 2024-11-06 | (m) |
| 2024-06-30 | 188.74M shares 10-Q · filed 2024-08-08 | (m) |
| 2024-03-31 | 180.19M shares 10-Q · filed 2024-05-02 | (m) |
| 2023-12-31 | 169.87M shares 10-K · filed 2025-03-27 | (m) |
| 2023-09-30 | 167.70M shares 10-Q · filed 2023-11-07 | (m) |
| 2023-06-30 | 166.92M shares 10-Q · filed 2023-08-03 | (m) |
| 2023-03-31 | 165.13M shares 10-Q · filed 2023-05-04 | (m) |
| 2022-12-31 | 157.46M shares 10-K · filed 2024-03-05 | (m) |
| 2022-09-30 | 152.71M shares 10-Q · filed 2022-11-09 | (m) |
| 2022-06-30 | 148.79M shares 10-Q · filed 2022-08-04 | (m) |
| 2022-03-31 | 148.73M shares 10-Q · filed 2022-05-05 | (m) |
| 2021-12-31 | 144.99M shares 10-K · filed 2023-03-02 | (m) |
| 2021-09-30 | 110.26M shares 10-Q · filed 2021-11-04 | (m) |
| 2021-06-30 | 97.70M shares 10-Q · filed 2021-08-05 | (m) |
| 2021-03-31 | 96.25M shares 10-Q · filed 2021-05-05 | (m) |
| 2020-12-31 | 89.68M shares 10-K · filed 2022-03-03 | (m) |
| 2020-09-30 | 84.62M shares 10-Q · filed 2020-11-05 | (m) |
| 2020-06-30 | 71.26M shares 10-Q · filed 2020-08-07 | (m) |
| 2020-03-31 | 56.85M shares 10-Q · filed 2020-05-11 | (m) |
| 2019-12-31 | 64.78M shares 10-K · filed 2021-03-04 | (m) |
| 2019-09-30 | 56.85M shares 10-Q · filed 2019-11-06 | (m) |
| 2019-06-30 | 56.85M shares 10-Q · filed 2019-08-05 | (m) |
| 2019-03-31 | 56.26M shares 10-Q · filed 2019-05-06 | (m) |
| 2018-12-31 | 55.52M shares 10-K · filed 2020-03-05 | (m) |
| 2018-09-30 | 55.47M shares 10-Q · filed 2018-11-07 | (m) |
| 2018-06-30 | 55.33M shares 10-Q · filed 2018-08-03 | (m) |
| 2018-03-31 | 55.09M shares 10-Q · filed 2018-05-04 | (m) |
| 2017-12-31 | 55.06M shares 10-K · filed 2019-03-07 | (m) |
| 2017-09-30 | 55.05M shares 10-Q · filed 2017-11-02 | (m) |
| 2017-06-30 | 55.03M shares 10-Q · filed 2017-08-03 | (m) |
| 2017-03-31 | 55.02M shares 10-Q · filed 2017-05-04 | (m) |
| 2016-12-31 | 54.84M shares 10-K · filed 2018-03-16 | (m) |
| 2016-09-30 | 54.84M shares 10-Q · filed 2016-11-03 | (m) |
| 2016-06-30 | 54.80M shares 10-Q · filed 2016-08-04 | (m) |
| 2016-03-31 | 54.63M shares 10-Q · filed 2016-05-04 | (m) |
| 2015-12-31 | 54.57M shares 10-K · filed 2017-03-22 | (m) |
| 2015-09-30 | 54.57M shares 10-Q · filed 2015-11-05 | (m) |
| 2015-06-30 | 54.30M shares 10-Q · filed 2015-08-07 | (m) |
| 2015-03-31 | 54.10M shares 10-Q · filed 2015-05-06 | (m) |
| 2014-12-31 | 22.44M shares 10-K · filed 2016-03-09 | (m) |
| 2014-09-30 | 22.28M shares 10-Q · filed 2014-11-07 | (m) |
| 2014-06-30 | 22.08M shares 10-Q · filed 2014-08-14 | (m) |
| 2014-03-31 | 21.99M shares 10-Q · filed 2014-05-14 | (m) |
| 2013-12-31 | 19.05M shares 10-K · filed 2015-03-13 | (m) |
| 2012-12-31 | 14.31M shares 10-K · filed 2014-03-28 | (m) |
| 2011-12-31 | 12.15M shares 20-F · filed 2013-03-27 | (m) |
| 2010-12-31 | 10.34M shares 20-F · filed 2012-03-27 | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |